Heme Oxygenase-1 : A Multifaceted Triple-Threat Molecule The Role of Heme Oxygenase-1 in Pulmonary Disease

Heme oxygenase (HO)-1, the inducible isoform of heme oxygenase, is a cytoprotective enzyme that plays a central role in the defense against oxidative and inflammatory insults in the lung. HO-1 catalyzes the degradation of heme, a potent oxidant, into biliverdin, iron, and carbon monoxide (CO). These downstream products of heme catabolism have recently been found to mediate the antioxidant, antiapoptotic, antiproliferative, vasodilatory, and anti-inflammatory properties of HO-1. Although absence of HO-1 is rare in humans, a number of HO-1 promoter polymorphisms have been identified that may influence HO-1 expression in vivo and lead to disease states. This review will summarize studies that implicate HO-1 and heme metabolites in the pathophysiology of pulmonary disease and discuss recent advances in the therapeutic applications of HO-1.

[1]  S. Ryter,et al.  Carbon monoxide and bilirubin: potential therapies for pulmonary/vascular injury and disease. , 2007, American journal of respiratory cell and molecular biology.

[2]  Jason M. Lynam,et al.  Bioactive Properties of Iron-Containing Carbon Monoxide-Releasing Molecules , 2006, Journal of Pharmacology and Experimental Therapeutics.

[3]  I. Rahman,et al.  Oxidant and antioxidant balance in the airways and airway diseases. , 2006, European journal of pharmacology.

[4]  R. Kinobe,et al.  Selectivity of imidazole–dioxolane compounds for in vitro inhibition of microsomal haem oxygenase isoforms , 2006, British journal of pharmacology.

[5]  S. Shibahara,et al.  Association of susceptibility to the development of pneumonia in the older Japanese population with haem oxygenase-1 gene promoter polymorphism , 2005, Journal of Medical Genetics.

[6]  C. Fann,et al.  Length polymorphism in heme oxygenase-1 is associated with arteriovenous fistula patency in hemodialysis patients. , 2006, Kidney international.

[7]  N. Terada,et al.  Heme oxygenase-1 mediates the protective effects of rapamycin in monocrotaline-induced pulmonary hypertension , 2006, Laboratory Investigation.

[8]  O. Wagner,et al.  Haem oxygenase‐1 genotype and cardiovascular adverse events in patients with peripheral artery disease , 2005, European journal of clinical investigation.

[9]  F. Liu,et al.  Biliverdin administration protects against endotoxin-induced acute lung injury in rats. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[10]  L. Fredenburgh,et al.  Absence of heme oxygenase-1 expression in the lung parenchyma exacerbates endotoxin-induced acute lung injury and decreases surfactant protein-B levels. , 2005, Cellular and molecular biology.

[11]  O. Wagner,et al.  Microsatellite polymorphism in the heme oxygenase-1 gene promoter and cardiac allograft vasculopathy. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[12]  S. Shibahara,et al.  Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to cerebral malaria in Myanmar. , 2005, Japanese journal of infectious diseases.

[13]  B. Williams.  Targeting specific cell types with silencing RNA. , 2005, The New England journal of medicine.

[14]  O. Wagner,et al.  Clinical restenosis after coronary stent implantation is associated with the heme oxygenase-1 gene promoter polymorphism and the heme oxygenase-1 +99G/C variant. , 2005, Clinical chemistry.

[15]  D. Pinsky,et al.  Reciprocal regulation of airway rejection by the inducible gas-forming enzymes heme oxygenase and nitric oxide synthase , 2005, The Journal of experimental medicine.

[16]  Y. Nagashima,et al.  Adenovirus-mediated transfer and overexpression of heme oxygenase 1 cDNA in lungs attenuates elastase-induced pulmonary emphysema in mice. , 2005, Human gene therapy.

[17]  Paul Talalay,et al.  Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. Choi,et al.  Carbon monoxide suppresses bleomycin-induced lung fibrosis. , 2005, The American journal of pathology.

[19]  H. Kubo,et al.  Association of susceptibility to the development of lung adenocarcinoma with the heme oxygenase-1 gene promoter polymorphism , 2005, Human Genetics.

[20]  O. Wagner,et al.  The role of heme oxygenase-1 promoter polymorphisms in human disease. , 2004, Free radical biology & medicine.

[21]  D. Postma,et al.  Heme oxygenase-1 expression in alveolar macrophages is elevated in patients with bronchiolitis obliterans syndrome after lung transplantation. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[22]  D. Zander,et al.  Heme oxygenase-1 expression in human lungs with cystic fibrosis and cytoprotective effects against Pseudomonas aeruginosa in vitro. , 2004, American journal of respiratory and critical care medicine.

[23]  M. Chung,et al.  Polymorphism in heme oxygenase-1 (HO-1) promoter is related to the risk of oral squamous cell carcinoma occurring on male areca chewers , 2004, British Journal of Cancer.

[24]  C. Song,et al.  Induction of heme oxygenase-1 is involved in anti-proliferative effects of paclitaxel on rat vascular smooth muscle cells. , 2004, Biochemical and biophysical research communications.

[25]  Y. Nagashima,et al.  Pseudomonas aeruginosa-induced neutrophilic lung inflammation is attenuated by adenovirus-mediated transfer of the heme oxygenase 1 cDNA in mice. , 2004, Human gene therapy.

[26]  M. Imamura,et al.  Continual emerging roles of HO-1: protection against airway inflammation. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[27]  P. Jose,et al.  Heme oxygenase attenuates allergen-induced airway inflammation and hyperreactivity in guinea pigs. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[28]  D. Zander,et al.  Heme-oxygenase-1 expression correlates with severity of acute cellular rejection in lung transplantation. , 2004, Journal of the American College of Surgeons.

[29]  A. Nicholson,et al.  Lung heme oxygenase-1 is elevated in acute respiratory distress syndrome , 2004, Critical care medicine.

[30]  H. Nonogi,et al.  A promoter variant of the heme oxygenase-1 gene may reduce the incidence of ischemic heart disease in Japanese. , 2004, Atherosclerosis.

[31]  Bok-Ryang Kim,et al.  Overexpression of heme oxygenase (HO)-1 renders Jurkat T cells resistant to fas-mediated apoptosis: involvement of iron released by HO-1. , 2004, Free radical biology & medicine.

[32]  D. Postma,et al.  Haem oxygenase‐1 expression is diminished in alveolar macrophages of patients with COPD , 2004, European Respiratory Journal.

[33]  Patty J. Lee,et al.  Small Interfering RNA Targeting Heme Oxygenase-1 Enhances Ischemia-Reperfusion-induced Lung Apoptosis* , 2004, Journal of Biological Chemistry.

[34]  H. Maeda,et al.  Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin , 2004, International journal of cancer.

[35]  G. Laurent,et al.  Attenuation of bleomycin induced pulmonary fibrosis in mice using the heme oxygenase inhibitor Zn-deuteroporphyrin IX-2,4-bisethylene glycol , 2004, Thorax.

[36]  O. Wagner,et al.  The effect of a promoter polymorphism in the heme oxygenase-1 gene on the risk of ischaemic cerebrovascular events: the influence of other vascular risk factors. , 2004, Thrombosis research.

[37]  F. Motoi,et al.  Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer , 2004, Angiogenesis.

[38]  K. Sanders,et al.  β1-Subunits are required for regulation of coupling between Ca2+ transients and Ca2+-activated K+ (BK) channels by protein kinase C , 2003 .

[39]  D. Zander,et al.  Graft protective effects of heme oxygenase 1 in mouse tracheal transplant-related obliterative bronchiolitis1 , 2003, Transplantation.

[40]  N. Iwai,et al.  Association of a promoter variant of the haeme oxygenase-1 gene with hypertension in women , 2003, Journal of hypertension.

[41]  A. Choi,et al.  Low-dose carbon monoxide reduces airway hyperresponsiveness in mice. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[42]  M. Benhamed,et al.  Heme Oxygenase Inhibits Human Airway Smooth Muscle Proliferation via a Bilirubin-dependent Modulation of ERK1/2 Phosphorylation* , 2003, Journal of Biological Chemistry.

[43]  Simon C Watkins,et al.  Carbon monoxide induces cytoprotection in rat orthotopic lung transplantation via anti-inflammatory and anti-apoptotic effects. , 2003, The American journal of pathology.

[44]  A. Zampetaki,et al.  Effect of Heme Oxygenase-1 Overexpression in Two Models of Lung Inflammation , 2003, Experimental biology and medicine.

[45]  N. Kohno,et al.  Genetic susceptibility for emphysematous changes of the lung in Japanese. , 2003, International journal of molecular medicine.

[46]  K. Nakayama,et al.  Relationship between microsatellite polymorphism in the haem oxygenase-1 gene promoter and longevity of the normal Japanese population , 2003, Journal of medical genetics.

[47]  D. Zander,et al.  Resistance to hyperoxia with heme oxygenase-1 disruption: role of iron. , 2003, Free radical biology & medicine.

[48]  Fang Liu,et al.  Carbon monoxide modulates endotoxin-induced production of granulocyte macrophage colony-stimulating factor in macrophages. , 2002, American journal of respiratory cell and molecular biology.

[49]  Y. Nagashima,et al.  Adenovirus-mediated transfer and overexpression of heme oxygenase 1 cDNA in lung prevents bleomycin-induced pulmonary fibrosis via a Fas-Fas ligand-independent pathway. , 2002, Human gene therapy.

[50]  A. Choi,et al.  Carbon monoxide inhibits human airway smooth muscle cell proliferation via mitogen-activated protein kinase pathway. , 2002, American journal of respiratory cell and molecular biology.

[51]  N. Abraham,et al.  Modulation of cGMP by human HO-1 retrovirus gene transfer in pulmonary microvessel endothelial cells. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[52]  D. Zander,et al.  Increased expression of heme oxygenase-1 in human lung transplantation. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[53]  D. Sugawara,et al.  Heme oxygenase-1 reduces murine monocrotaline-induced pulmonary inflammatory responses and resultant right ventricular overload. , 2002, Antioxidants & redox signaling.

[54]  Y. Soini,et al.  Up-regulation of heme oxygenase-I in alveolar macrophages of newly diagnosed asthmatics. , 2002, Respiratory medicine.

[55]  Hidetada Sasaki,et al.  Bilirubin ameliorates bleomycin-induced pulmonary fibrosis in rats. , 2002, American journal of respiratory and critical care medicine.

[56]  Y. Soini,et al.  Expression and regulation of hemeoxygenase 1 in healthy human lung and interstitial lung disorders. , 2001, Human pathology.

[57]  L. Fabbri,et al.  Increased expression of heme oxygenase (HO)-1 in alveolar spaces and HO-2 in alveolar walls of smokers. , 2001, American journal of respiratory and critical care medicine.

[58]  Y. Nagashima,et al.  Adenovirus-mediated transfer of heme oxygenase-1 cDNA attenuates severe lung injury induced by the influenza virus in mice , 2001, Gene Therapy.

[59]  T. Matsuyama,et al.  Heme oxygenase‐1 (HO‐1) protein induction in a mouse model of asthma , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[60]  Martha Kirby,et al.  Regulation of CSF1 Promoter by the SWI/SNF-like BAF Complex , 2001, Cell.

[61]  T. Minamino,et al.  Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[62]  James L. Park,et al.  Heme oxygenase-1 protects against vascular constriction and proliferation , 2001, Nature Medicine.

[63]  Y. Nagashima,et al.  Transfer of heme oxygenase 1 cDNA by a replication-deficient adenovirus enhances interleukin 10 production from alveolar macrophages that attenuates lipopolysaccharide-induced acute lung injury in mice. , 2001, Human gene therapy.

[64]  D. Pinsky,et al.  Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis , 2001, Nature Medicine.

[65]  K. Maemura,et al.  Endotoxin-Induced Mortality Is Related to Increased Oxidative Stress and End-Organ Dysfunction, Not Refractory Hypotension, in Heme Oxygenase-1–Deficient Mice , 2000, Circulation.

[66]  I. Adcock,et al.  Expression of heme oxygenase isoenzymes 1 and 2 in normal and asthmatic airways: effect of inhaled corticosteroids. , 2000, American journal of respiratory and critical care medicine.

[67]  C. Contag,et al.  HO-1 expression in type II pneumocytes after transpulmonary gene delivery. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[68]  A. Choi,et al.  Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway , 2000, Nature Medicine.

[69]  P. Barnes,et al.  Increase in exhaled carbon monoxide during exacerbations of cystic fibrosis , 2000, Thorax.

[70]  S. Shibahara,et al.  Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. , 2000, American journal of human genetics.

[71]  L. Kobzik,et al.  Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. , 1999, The Journal of clinical investigation.

[72]  A. Choi,et al.  Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. , 1999, The Journal of clinical investigation.

[73]  S. Ishizuka,et al.  Exhaled carbon monoxide levels during treatment of acute asthma. , 1999, The European respiratory journal.

[74]  P. Dennery,et al.  Protective effects of transient HO-1 overexpression on susceptibility to oxygen toxicity in lung cells. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[75]  Y. Niida,et al.  Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. , 1999, The Journal of clinical investigation.

[76]  I. Horváth,et al.  Changes in exhaled carbon monoxide and nitric oxide levels following allergen challenge in patients with asthma. , 1999, The European respiratory journal.

[77]  M. Carraway,et al.  Lung-specific induction of heme oxygenase-1 and hyperoxic lung injury. , 1998, The American journal of physiology.

[78]  S. Kourembanas,et al.  Carbon Monoxide Controls the Proliferation of Hypoxic Vascular Smooth Muscle Cells* , 1997, The Journal of Biological Chemistry.

[79]  S. Tonegawa,et al.  Reduced stress defense in heme oxygenase 1-deficient cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[80]  A Bast,et al.  Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. , 1997, American journal of respiratory and critical care medicine.

[81]  C. Hsieh,et al.  Prevention of Hypoxia-Induced Pulmonary Hypertension by Enhancement of Endogenous Heme Oxygenase-1 in the Rat. • 238 , 1997, Pediatric Research.

[82]  H. Fessler,et al.  Mechanism of hemoglobin-induced protection against endotoxemia in rats: a ferritin-independent pathway. , 1997, The American journal of physiology.

[83]  A. Choi,et al.  Overexpression of heme oxygenase-1 in human pulmonary epithelial cells results in cell growth arrest and increased resistance to hyperoxia. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[84]  A. Choi,et al.  Regulation of heme oxygenase-1 expression in vivo and in vitro in hyperoxic lung injury. , 1996, American journal of respiratory cell and molecular biology.

[85]  R. Winslow,et al.  NO-mediated activation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium. , 1996, The American journal of physiology.

[86]  A. Choi,et al.  Hemoglobin provides protection against lethal endotoxemia in rats: the role of heme oxygenase-1. , 1995, American journal of respiratory cell and molecular biology.

[87]  A. Choi,et al.  Induction of heme oxygenase-1 gene expression by lipopolysaccharide is mediated by AP-1 activation. , 1995, American journal of respiratory cell and molecular biology.

[88]  S. Kourembanas,et al.  Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[89]  J. Eaton,et al.  Ferritin: a cytoprotective antioxidant strategem of endothelium. , 1992, The Journal of biological chemistry.

[90]  L. Naylor,et al.  d(TG)n.d(CA)n sequences upstream of the rat prolactin gene form Z-DNA and inhibit gene transcription. , 1990, Nucleic acids research.

[91]  B. Brüne,et al.  Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. , 1987, Molecular pharmacology.

[92]  B. Ames,et al.  Bilirubin is an antioxidant of possible physiological importance. , 1987, Science.

[93]  H. Marver,et al.  The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. , 1968, Proceedings of the National Academy of Sciences of the United States of America.